These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18442895)

  • 21. IL-23 promotes tumour incidence and growth.
    Langowski JL; Zhang X; Wu L; Mattson JD; Chen T; Smith K; Basham B; McClanahan T; Kastelein RA; Oft M
    Nature; 2006 Jul; 442(7101):461-5. PubMed ID: 16688182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin 2 and systemic lupus erythematosus: beyond the transcriptional regulatory net abnormalities.
    Gómez-Martín D; Díaz-Zamudio M; Crispín JC; Alcocer-Varela J
    Autoimmun Rev; 2009 Sep; 9(1):34-9. PubMed ID: 19269352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular and cellular mechanisms of photocarcinogenesis.
    Beissert S; Loser K
    Photochem Photobiol; 2008; 84(1):29-34. PubMed ID: 18173698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-2 in the development and control of inflammatory disease.
    Hoyer KK; Dooms H; Barron L; Abbas AK
    Immunol Rev; 2008 Dec; 226():19-28. PubMed ID: 19161413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokines and T-cell homeostasis.
    Boyman O; Purton JF; Surh CD; Sprent J
    Curr Opin Immunol; 2007 Jun; 19(3):320-6. PubMed ID: 17433869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-10 in the brain.
    Strle K; Zhou JH; Shen WH; Broussard SR; Johnson RW; Freund GG; Dantzer R; Kelley KW
    Crit Rev Immunol; 2001; 21(5):427-49. PubMed ID: 11942558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myelopeptide-2 recovers interleukin-2 synthesis and interleukin-2 receptor expression in human T lymphocytes depressed by tumor products or measles virus.
    Mikhailova AA; Belevskaya RG; Kalyuzhnaya M; Fonina LA; Liashenko VA; Petrov RV
    J Immunother; 2006; 29(3):306-12. PubMed ID: 16699373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell biology of IL-7, a key lymphotrophin.
    Jiang Q; Li WQ; Aiello FB; Mazzucchelli R; Asefa B; Khaled AR; Durum SK
    Cytokine Growth Factor Rev; 2005; 16(4-5):513-33. PubMed ID: 15996891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Y1 receptor for NPY: a key modulator of the adaptive immune system.
    Wheway J; Herzog H; Mackay F
    Peptides; 2007 Feb; 28(2):453-8. PubMed ID: 17240480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic administration of interleukin-2.
    Chavez AR; Buchser W; Basse PH; Liang X; Appleman LJ; Maranchie JK; Zeh H; de Vera ME; Lotze MT
    Ann N Y Acad Sci; 2009 Dec; 1182():14-27. PubMed ID: 20074271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of fibrosis by the immune system.
    Lupher ML; Gallatin WM
    Adv Immunol; 2006; 89():245-88. PubMed ID: 16682276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-17 in post-stroke neurodegeneration.
    Swardfager W; Winer DA; Herrmann N; Winer S; Lanctôt KL
    Neurosci Biobehav Rev; 2013 Mar; 37(3):436-47. PubMed ID: 23370232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of interleukin-2 gene transcription: a paradigm for inducible, tissue-specific gene expression.
    Bunting K; Wang J; Shannon MF
    Vitam Horm; 2006; 74():105-45. PubMed ID: 17027513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-35: a potential target for the treatment of atherosclerosis.
    Huang Y; Lin YZ; Shi Y; Ji QW
    Pharmazie; 2013 Oct; 68(10):793-5. PubMed ID: 24273881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modification of iron regulation by the inflammatory response.
    Weiss G
    Best Pract Res Clin Haematol; 2005 Jun; 18(2):183-201. PubMed ID: 15737884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanometer-scale organization of the alpha subunits of the receptors for IL2 and IL15 in human T lymphoma cells.
    de Bakker BI; Bodnár A; van Dijk EM; Vámosi G; Damjanovich S; Waldmann TA; van Hulst NF; Jenei A; Garcia-Parajo MF
    J Cell Sci; 2008 Mar; 121(Pt 5):627-33. PubMed ID: 18287585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A biophysical approach to IL-2 and IL-15 receptor function: localization, conformation and interactions.
    Bodnár A; Nizsalóczki E; Mocsár G; Szalóki N; Waldmann TA; Damjanovich S; Vámosi G
    Immunol Lett; 2008 Mar; 116(2):117-25. PubMed ID: 18280585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overview of interleukin-2 function, production and clinical applications.
    Gaffen SL; Liu KD
    Cytokine; 2004 Nov; 28(3):109-23. PubMed ID: 15473953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory T cells in HIV infection: pathogenic or protective participants in the immune response?
    Fazekas de St Groth B; Landay AL
    AIDS; 2008 Mar; 22(6):671-83. PubMed ID: 18356596
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of interleukin-2 during homeostasis and activation of the immune system.
    Boyman O; Sprent J
    Nat Rev Immunol; 2012 Feb; 12(3):180-90. PubMed ID: 22343569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.